Avantis U.S. Equity Fund BMY Holdings History
Avantis U.S. Equity Fund's Bristol-Myers Squibb Co Holding Summary
As of 2025-02-28, AMERICAN CENTURY ETF TRUST held 667.00 shares of Bristol-Myers Squibb Co(BMY), totaling $470.00. This investment constitutes 0% of their stock portfolio, and AMERICAN CENTURY ETF TRUST now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2020Q1. And since then Avantis U.S. Equity Fund has made 7 purchases of BMY, at an average price of $55.24, for a total of 103,420.00 shares. In addition, there have been 4 sales at an average price of $52.82 for 102,753.00 shares. Based on historical transaction data and BMY's current price of $46.85, Avantis U.S. Equity Fund's estimated gain on his BMY holdings is $-253,409.55, reflecting a -4.44% gain to date.
Avantis U.S. Equity Fund BMY ($46.85) Holding Chart
Avantis U.S. Equity Fund BMY ($46.85) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1